about
Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patientsIdentification of Novel Short Ragweed Pollen Allergens Using Combined Transcriptomic and Immunoproteomic ApproachesThe minor house dust mite allergen Der p 13 is a fatty acid-binding protein and an activator of a TLR2-mediated innate immune response.New insights into ragweed pollen allergens.Allergen extracts for immunotherapy: to mix or not to mix?The House Dust Mite Major Allergen Der p 23 Displays O-Glycan-Independent IgE Reactivities but No Chitin-Binding Activity.Allergen immunotherapy for birch pollen-allergic patients: recent advances.Standardization of allergen products: 3. Validation of candidate European Pharmacopoeia standard methods for quantification of major birch allergen Bet v 1.Proteomics for Allergy: from Proteins to the Patients.Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions.Identification of the cysteine protease Amb a 11 as a novel major allergen from short ragweed.A combined transcriptome and proteome analysis extends the allergome of house dust mite Dermatophagoides species.Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapy.Recombinant fusion proteins assembling Der p 1 and Der p 2 allergens from Dermatophagoides pteronyssinus.Advances in the quantification of relevant allergens in allergenic extracts.Mass spectrometric investigation of molecular variability of grass pollen group 1 allergens.Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.Specific IgE recognition of pollen allergens from subtropic grasses in patients from the subtropics.Validation of ELISA methods for quantification of the major birch allergen Bet v 1 (BSP090).The Blomia tropicalis allergen Blo t 7 stimulates innate immune signaling pathways through TLR2.Characterization of epitope specificities of reference antibodies used for the quantification of the birch pollen allergen Bet v 1.The Bioavailability of Allergens in Allergy Tablets Depends on Several Factors.Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma.Sialylated Fetuin-A as a candidate predictive biomarker for successful grass pollen allergen immunotherapy.Bioinspired Design and Oriented Synthesis of Immunogenic Site-Specifically Penicilloylated Peptides.Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy.Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparationExpression and characterization of natural-like recombinant Der p 2 for sublingual immunotherapyIdentification of a new phenotype of tolerogenic human dendritic cells induced by fungal proteases from Aspergillus oryzaeA regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapyAnti-inflammatory activity of sublingual immunoglobulin (SLIG) in a murine model of allergen-driven airway inflammationApplication of proteomics for the characterization of biological allergen extractsQuality control of house dust mite extracts for allergen immunotherapyThe house dust mite allergen Der p 5 binds lipid ligands and stimulates airway epithelial cells through a TLR2-dependent pathwayCCR10+ ILC2s with ILC1-like properties exhibit a protective function in severe allergic asthmaMolecular and functional characterization of natural allergen extracts
P50
Q27700098-DA5921A7-9C9E-4486-8DE8-8E6EB509BA96Q35758688-2633CBCF-D55B-4570-AFBF-38B936957045Q35971364-77B268F0-FF1D-4655-9160-3F4EE9B9CEFAQ38588967-9F8FEA77-C681-4885-BBAE-CD020AD755D8Q38664847-D651882D-4790-4350-BDF5-A227A46289D3Q38800663-244CDB12-7BF9-4E3A-9EF8-CD328A1E9AD2Q38824177-96A3A3AD-B971-4ECB-9800-4D43CB9F4CF1Q38889615-0F1A8087-3515-46BE-9D38-731AEF25E6B6Q38930142-85349508-4FFB-4A1A-8C91-1FBC38ED5570Q40342917-05E1DCC8-7712-464A-8AD3-1EBB93272410Q41085861-647A9348-145A-425B-BF72-BBF969A67B56Q42370773-69560790-F5BC-4A57-A36A-6E50CE79ED9EQ42638787-B095C736-944D-4AFC-AE19-8991D8E4C278Q43091410-5065334D-C44F-42B4-8CBF-9E9AC5332CB0Q44273894-E77845FB-CBC4-489C-B499-07F9479DC5C2Q45942239-721D5996-58B3-4ABE-9218-7B1BD189FE57Q46651312-F03B476C-B9E1-4232-B431-9760F0B7055EQ46763630-F3A45B28-8576-4F24-ACA2-E7022D8E56D0Q47612557-F265C535-958B-4009-8C4C-04C9B3158733Q47651344-F0A5A5D7-E5C1-4EAC-AE08-53BECF504AFFQ48240468-A579E583-5CE0-4147-A5D9-4947E13FF7D8Q50133992-99F609DE-1C7C-4317-947D-604DF6D68D77Q51070419-BDF98FEA-7421-4679-9BFD-D8A187323CE2Q51269211-63984AEF-1AC8-49F6-88C1-420F7DCC0D38Q51555589-FB146F09-4C87-419D-BAC8-402DDEB70893Q53292812-10692141-2F78-4A83-B1C7-072EFF840245Q58490825-6EDF121D-6925-41AA-A525-34CE05360056Q83350803-4EB5DE5C-FEE6-4AF4-AC07-1CEAE6D51261Q83516305-7D68762F-1695-4A68-B440-F5267D802592Q83781226-F5FEFDBA-7707-496B-8E3B-2AF3B727EAEAQ84549496-96027BE7-CF6C-4AD1-8270-B961828B79AFQ84962096-4B555B94-EAAC-43A6-BE07-24E9DFB0B101Q86522998-E66F3652-A640-4F21-9C07-A3842DF85CA6Q91533217-9FA2923E-5AB3-4CB7-8EEF-28F3E79F5EA6Q93366244-B3473949-2A81-4EA3-AB18-3B4105B226B3Q95404760-7AAD0782-66C1-47AE-AF32-17ED7BE52625
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Emmanuel Nony
@ast
Emmanuel Nony
@en
Emmanuel Nony
@es
Emmanuel Nony
@nl
Emmanuel Nony
@sl
type
label
Emmanuel Nony
@ast
Emmanuel Nony
@en
Emmanuel Nony
@es
Emmanuel Nony
@nl
Emmanuel Nony
@sl
prefLabel
Emmanuel Nony
@ast
Emmanuel Nony
@en
Emmanuel Nony
@es
Emmanuel Nony
@nl
Emmanuel Nony
@sl
P106
P31
P496
0000-0003-1820-8881